| Announce Date | 10/29/2025 |
| EPS Normalized Actual | $4.26 (Beat by $0.04) |
| EPS GAAP Actual | $4.26 (Beat by $0.04) |
| Revenue Actual | $2.06701B |
| Revenue Surprise | Beat by $2067.01M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $0 |
| EPS GAAP Estimate | $0 |
| Revenue Estimate | $1.751481895B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 21.08 | 19.89 | 20.17965 | 21.51091 | 1 |
| Dec 2028 | 17.2472 | 24.31 | 16.83244 | 17.94955 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 3.98 | -1.06019 | 2.06701B | -4.5% | -300.93M |
| FQ2 2025 (Jun 2025) | 4.57 | -0.53511 | 2.06244B | -3.73% | -300.63M |
| FQ1 2025 (Mar 2025) | 1.93 | 1.93 | 1.53109B | -2.21% | 1531.09M |
| FQ4 2024 (Dec 2024) | 2.57 | 2.57 | 1.75396B | 100% | 1753.96M |
| FQ3 2024 (Sep 2024) | 4.57 | 4.57 | 2.16004B | 1.54% | 2160.04M |
| FQ2 2024 (Jun 2024) | 0 | 0 | 2.13933B | 6.37% | 2139.33M |
| FQ1 2024 (Mar 2024) | 0 | 0 | 1.56499B | 0.92% | 1564.99M |
| FQ4 2023 (Dec 2023) | 0 | 0 | 0B | NAN% | 0M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
0
Consensus Revenue Estimates
1.751481895B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 2.89 | -- | 2.7952 | 3.00876 | 1 |
| FQ3 2027 (Sep 2027) | 5.45 | -- | 5.27123 | 5.67395 | 1 |
| FQ2 2027 (Jun 2027) | 6.17 | -- | 5.96762 | 6.42354 | 1 |
| FQ1 2027 (Mar 2027) | 2.87 | -- | 2.77586 | 2.98794 | 1 |
| FQ4 2026 (Oct 2026) | 5.95695 | -- | 5.95695 | 5.95695 | 0 |
| FQ3 2026 (Jul 2026) | 5.52048 | 27.9 | 5.52048 | 5.52048 | 0 |
| FQ2 2026 (Jun 2026) | 5.52048 | 17.22 | 5.52048 | 5.52048 | 0 |
| FQ1 2026 (Mar 2026) | 0 | -INF | 0 | 0 | 0 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 1.94B | -- | 1.89B | 2.01B | 9 |
| FQ3 2027 (Sep 2027) | 2.47B | -- | 2.41B | 2.55B | 9 |
| FQ2 2027 (Jun 2027) | 2.59B | -- | 2.52B | 2.67B | 9 |
| FQ1 2027 (Mar 2027) | 1.88B | -- | 1.84B | 1.94B | 9 |
| FQ4 2026 (Oct 2026) | 2.57B | -- | 2.57B | 2.57B | 0 |
| FQ3 2026 (Jul 2026) | 2.47B | 16.32 | 2.47B | 2.47B | 0 |
| FQ2 2026 (Jun 2026) | 2.47B | 16.51 | 2.47B | 2.47B | 0 |
| FQ1 2026 (Mar 2026) | 1.75B | 12.58 | 1.75B | 1.75B | 0 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
3
EPS # of Misses
2
EPS # of in-lines
3
Revenue # of Beats
5
Revenue # of Misses
2
Revenue # of in-lines
1
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 5.04019 | 3.98 | -1.06019 | -26.64% |
| FQ2 2025 (Jun 2025) | 5.10511 | 4.57 | -0.53511 | -11.71% |
| FQ1 2025 (Mar 2025) | 1.93 | 1.93 | 100% | |
| FQ4 2024 (Dec 2024) | 2.57 | 2.57 | 100% | |
| FQ3 2024 (Sep 2024) | 4.57 | 4.57 | 100% | |
| FQ2 2024 (Jun 2024) | 0 | 0 | NAN% | |
| FQ1 2024 (Mar 2024) | 0 | 0 | NAN% | |
| FQ4 2023 (Dec 2023) | 0 | 0 | NAN% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $2.37B | $2.07B | $-300.93M | -14.56% |
| FQ2 2025 (Jun 2025) | $2.36B | $2.06B | $-300.63M | -14.58% |
| FQ1 2025 (Mar 2025) | $0B | $1.53B | $1531.09M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $1.75B | $1753.96M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $2.16B | $2160.04M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $2.14B | $2139.33M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $1.56B | $1564.99M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $0B | $0M | NAN% |